Global News

PPD, GA2LEN form strategic alliance in allergic diseases

Monday, September 17, 2012 10:38 AM

Pharmaceutical Product Development (PPD), a global CRO, and the Global Allergy and Asthma European Network (GA²LEN), a multidisciplinary research network, have formed a strategic alliance in which GA²LEN will provide PPD access to the network's allergy and asthma experts and to more than 100 allergy and asthma sites in Europe.

More... »

AMRI promotes Daniel Conlon to senior director of business development

Friday, September 14, 2012 12:51 PM

AMRI, a global contract research and manufacturing organization, has promoted Daniel Conlon to senior director of business development.

More... »

C-Path and CDISC launch CFAST

Friday, September 14, 2012 12:35 PM

The Clinical Data Interchange Standards Consortium (CDISC), a global non-profit charitable organization, and Critical Path Institute (C-Path), a Tucson, Ariz.-based non-profit organization committed to improving human health and well-being, have launched their joint Coalition For Accelerating Standards and Therapies (CFAST), a follow-up to the partnership agreement signed earlier this year.

More... »

Report: Healthcare, regulatory and reimbursement landscape - Mexico

Friday, September 14, 2012 11:28 AM

Industry analysis specialist GlobalData has released its new report, Healthcare, Regulatory and Reimbursement Landscape – Mexico, which identifies the key trends in the Mexican healthcare market, as well as providing insights on the demographic, regulatory and reimbursement landscape, and the healthcare infrastructure of Mexico.

More... »

Vascular Pharma completes $16M equity financing, signs agreement with Janssen

Thursday, September 13, 2012 08:00 AM

Vascular Pharmaceuticals, a drug discovery company developing a product to treat patients with complications arising from diabetes, has successfully completed a $16 million Series A equity financing.

More... »

Spectrum appoints Amgen vet Ken Keller as COO

Thursday, September 13, 2012 08:00 AM

Spectrum Pharmaceuticals, a biotechnology company focused on hematology and oncology, has appointed Ken Keller as executive vice president and COO. Keller will have global responsibility for leading commercial operations, medical and clinical development and pharmaceutical operations.

More... »

Mytrus’ informed consent iPad app to be used in multi-year global clinical trial

Wednesday, September 12, 2012 12:11 PM

Mytrus, a San Francisco-based innovative clinical technology and services company, announced that its iPad application explaining informed consent prior to clinical trial patient enrollment has been selected for use in a global, multi-year study supported by the National Institute of Neurological Disorders and Stroke (NINDS).

More... »

Leading researchers outline principles for conduct of comparative effectiveness research

Wednesday, September 12, 2012 11:51 AM

A new set of principles developed by a group of leading researchers could help to ensure more consistency in how comparative effectiveness research (CER) is planned and conducted. These guiding principles were published in the September issue of The Journal of Comparative Effectiveness Research.

More... »

Welch Allyn restructures business, cuts 10% of workforce

Wednesday, September 12, 2012 10:26 AM

Welch Allyn, a global provider of frontline medical products and solutions based in Skaneateles Falls, N.Y., will reshape its business and realign resources over the next three years.

More... »

Takeda completes its Russian pharmaceutical manufacturing facility

Wednesday, September 12, 2012 09:39 AM

Takeda Pharmaceutical International, a Zurich-based wholly owned subsidiary of Takeda Pharmaceutical Company, has completed construction at its pharmaceutical manufacturing facility in Yaroslavl, Russia.

More... »